stockgist
HomeTop MoversCompaniesConcepts

Market

  • Top Movers
  • Companies
  • Concepts

SEC Filings

  • AI Filing Analysis
  • Financial Reports
  • Current Reports
  • IPO Filings

Ownership

  • Institutional Holdings
  • Insider Trading

About

  • Data updates every 5 min
  • SEC EDGAR Source
© 2025–2026 StockGist|Information only, not investment advice
    1. Companies
    2. INSD
    stockgist
    HomeTop MoversCompaniesConcepts
    INSD logo

    Instadose Pharma Corp.

    INSD
    OTC
    Healthcare
    Drug Manufacturers - Specialty & Generic
    Chesapeake, VA, US2 employeesinstadosepharma.com
    —

    At A Glance

    1

    Instadose Pharma Corp.

    2

    No significant events in the past 90 days.

    —

    Market Cap

    —

    Revenue

    —

    Net Income

    Employees2
    Fundamentals

    How The Business Makes Money

    Instadose Pharma Corp. engages in growing, cultivation, processing, and global distribution of medical-grade cannabinoid oil. The company was founded in 2017 and is based in Burlington, Canada.

    Industry Drug Manufacturers - Specialty & Generic
    Activity

    What Changed Recently

    No significant events in the past 90 days.

    Peer Companies

    CompanyPriceChangeMarket CapP/E
    NUNZNunzia Pharmaceutical Com...————
    LRDSFLords & Company Worldwide...————
    MHTXManhattan Scientifics, In...————
    BIOIFBiome Grow Inc.————
    ISOLFIsodiol International Inc...————
    QEBRVirtual Medical Internati...————
    OWCPOWC Pharmaceutical Resear...————
    ATTBFAbattis Bioceuticals Corp...————
    Company Profile
    CIK0001697587
    ISINUS45783B1035
    Phone800-701-4342
    Address1545 Crossways Blvd, Chesapeake, VA, L7L 6W6, US
    SEC EDGAR

    Market

    • Top Movers
    • Companies
    • Concepts

    SEC Filings

    • AI Filing Analysis
    • Financial Reports
    • Current Reports
    • IPO Filings

    Ownership

    • Institutional Holdings
    • Insider Trading

    About

    • Data updates every 5 min
    • SEC EDGAR Source
    © 2025–2026 StockGist|Information only, not investment advice